Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Peters

Showing results (661-670 of 685) with videos related to

Pageof 69
Sort By:
Cancers|January 8, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective StudyAmina Banda, Bastiaan M Privé, Youssra Allach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study GroupSamantha J Mayo, Maryam Lustberg, Haryana M Dhillon, et al.
Therapeutic Advances in Respiratory Disease|September 28, 2019
Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitationYvonne M J Goërtz, Martijn A Spruit, Alex J Van 't Hul, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Clinical Breast Cancer|November 25, 2023
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE RegistryKhava I E Ibragimova, Sandra M E Geurts, Dávid Laczkó, et al.
The Lancet Regional Health. Europe|March 10, 2023
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE RegistryMarissa Meegdes, Sandra M E Geurts, Frans L G Erdkamp, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Scientific Reports|October 26, 2021
Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort StudyYvonne M J Goërtz, Annemarie M J Braamse, Martijn A Spruit, et al.
Breast Cancer Research and Treatment|October 25, 2023
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registrySenna W M Lammers, Hannah Thurisch, Ingeborg J H Vriens, et al.
Breast Cancer Research and Treatment|January 13, 2022
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registryMarissa Meegdes, Khava I E Ibragimova, Dorien J A Lobbezoo, et al.
Pageof 69

Showing results (661-670 of 685) with videos related to

Sort By:
Pageof 69
Cancers|January 8, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective StudyAmina Banda, Bastiaan M Privé, Youssra Allach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study GroupSamantha J Mayo, Maryam Lustberg, Haryana M Dhillon, et al.
Therapeutic Advances in Respiratory Disease|September 28, 2019
Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitationYvonne M J Goërtz, Martijn A Spruit, Alex J Van 't Hul, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Clinical Breast Cancer|November 25, 2023
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE RegistryKhava I E Ibragimova, Sandra M E Geurts, Dávid Laczkó, et al.
The Lancet Regional Health. Europe|March 10, 2023
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE RegistryMarissa Meegdes, Sandra M E Geurts, Frans L G Erdkamp, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Scientific Reports|October 26, 2021
Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort StudyYvonne M J Goërtz, Annemarie M J Braamse, Martijn A Spruit, et al.
Breast Cancer Research and Treatment|October 25, 2023
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registrySenna W M Lammers, Hannah Thurisch, Ingeborg J H Vriens, et al.
Breast Cancer Research and Treatment|January 13, 2022
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registryMarissa Meegdes, Khava I E Ibragimova, Dorien J A Lobbezoo, et al.
Pageof 69